Lineage Cell Therapeutics
LCTX
#8657
Rank
$0.11 B
Marketcap
$0.60
Share price
-6.45%
Change (1 day)
-43.93%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Net assets

Net assets on the balance sheet as of June 2024 : $66.87 Million USD

According to Lineage Cell Therapeutics 's latest financial reports the company has $66.87 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$62.02 M-13.78%
2022-12-31$$71.93 M-20.86%
2021-12-31$$90.89 M-4.45%
2020-12-31$$95.12 M-14.49%
2019-12-31$$0.11 B20.6%
2018-12-31$$92.24 M-43.84%
2017-12-31$$0.16 B25.86%
2016-12-31$$0.13 B70.72%
2015-12-31$$76.44 M21.88%
2014-12-31$$62.72 M48.41%
2013-12-31$$42.26 M73.96%
2012-12-31$$24.29 M-41.4%
2011-12-31$$41.45 M-16.12%
2010-12-31$$49.42 M347.41%
2009-12-31$$11.04 M-354.14%
2008-12-31$-$4.35 Million42.69%
2007-12-31$-$3.05 Million63.33%
2006-12-31$-$1.87 Million848.83%
2005-12-31$-$0.2 Million-157.02%
2004-12-31$$0.34 M-114.18%
2003-12-31$-$2.44 Million107.54%
2002-12-31$-$1.18 Million1081.85%
2001-12-31$-$0.1 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$0.30 B 352.19%๐Ÿ‡บ๐Ÿ‡ธ USA